共 185 条
[1]
Schofield DJ(2013)The personal and national costs of lost labour force participation due to arthritis: an economic study BMC Public Health. 13 188-3
[2]
Shrestha RN(2008)Guideline Development Group. Care and management of osteoarthritis in adults: summary of NICE guidance BMJ. 336 502-99
[3]
Percival R(2010)OARSI recommendations for the management of hip and knee osteoarthritis: part III: Changes in evidence following systematic cumulative update of research published through January 2009 Osteoarthritis Cartilage. 18 476-56
[4]
Passey ME(2012)Osteoarthritis: diagnosis and treatment Am Fam Physician. 85 49-42
[5]
Callander EJ(2007)Viscosupplementation with hyaluronans for osteoarthritis of the knee: clinical efficacy and economic implications Drugs Aging. 24 629-19
[6]
Kelly SJ(2007)Viscosupplementation: managed care issues for osteoarthritis of the knee J Manag Care Pharm. 4 S3-21
[7]
Conaghan PG(2007)Total knee replacement delayed with Hylan G-F 20 use in patients with grade IV osteoarthritis J Manag Care Pharm. 13 113-14
[8]
Dickson J(2013)Cost-analysis of viscosupplementation treatment with hyaluronic acid in candidate knee replacement patients with osteoarhritis Rev Esp Cir Ortop Traumatol. 57 6-205
[9]
Grant RL(2010)Isolated patellofemoral osteoarthritis Acta Orthop. 81 199-20
[10]
Zhang W(2013)Complications of total knee arthroplasty: standardized list and definitions of the Knee Society Clin Orthop Relat Res. 471 215-11